statistical software medcalc 12.1.4.0 (MedCalc Software Ltd)
90
Structured Review
MedCalc Software Ltd
statistical software medcalc 12.1.4.0
Statistical Software Medcalc 12.1.4.0, supplied by MedCalc Software Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/12%2E1%2E4%2E0+statistical+software/medcalc+9+0+1/pm40050905-91-6-10
Average 90 stars, based on 1 article reviews
Statistical Software Medcalc 12.1.4.0, supplied by MedCalc Software Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/12%2E1%2E4%2E0+statistical+software/medcalc+9+0+1/pm40050905-91-6-10
Average 90 stars, based on 1 article reviews
statistical software medcalc 12.1.4.0 - by Bioz Stars,
2026-09
90/100 stars
Images
Related Articles
other:Article Title: H3K27me3 Immunohistochemical Loss Predicts Lower Response to Neo-Adjuvant Chemo-Radiotherapy in Rectal Carcinoma Article Snippet: Statistical analyses were performed using Article Title: The Immunohistochemical Loss of H3K27me3 in Intracranial Meningiomas Predicts Shorter Progression-Free Survival after Stereotactic Radiosurgery Article Snippet: Statistical analyses were performed using Article Title: Molecular Profiling of 22 Primary Atypical Meningiomas Shows the Prognostic Significance of 18q Heterozygous Loss and CDKN2A/B Homozygous Deletion on Recurrence-Free Survival Article Snippet: Statistical analysis was performed using Article Title: Clinical Impact and Prognostic Role of KRAS/BRAF/PIK3CA Mutations in Stage I Colorectal Cancer Article Snippet: Statistical analysis was done using Article Title: The presence of poorly differentiated clusters predicts survival in stage II colorectal cancer. Article Snippet: In stage II colorectal carcinoma (CRC), adjuvant chemotherapy is reserved to cases at high risk of adverse outcome.. This study aims to investigate the prognostic value of tumor budding (TB) and poorly differentiated clusters (PDC) in this setting.. In a cohort of 149 patients with surgically resected stage II CRC not undergoing neoadjuvant or adjuvant treatments, we assessed the prognostic value of several clinical-pathological variables, including PDC and TB, on cancer-specific survival (CSS). Article Title: The histopathological diagnosis of atypical meningioma: glass slide versus whole slide imaging for grading assessment Article Snippet: Statistical analysis was performed using the Article Title: Prevalence of Undiagnosed Diabetes and Prediabetes in the Dental Setting: A Systematic Review and Meta-Analysis Article Snippet: All analyses were performed using Article Title: Atypical meningiomas with an immunohistochemical profile consistent with hypermetabolic or proliferative molecular groups show high mitotic index, chromosomal instability, and higher recurrence risk Article Snippet: Statistical analysis was performed using the |